These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24326545)

  • 41. Tofacitinib for the treatment of moderate-to-severe psoriasis.
    Chiricozzi A; Faleri S; Saraceno R; Bianchi L; Buonomo O; Chimenti S; Chimenti MS
    Expert Rev Clin Immunol; 2015 Apr; 11(4):443-55. PubMed ID: 25666451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti-IL-2Rα therapies.
    Volkó J; Kenesei Á; Zhang M; Várnai P; Mocsár G; Petrus MN; Jambrovics K; Balajthy Z; Müller G; Bodnár A; Tóth K; Waldmann TA; Vámosi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21120-21130. PubMed ID: 31570576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.
    Morandi B; Mortara L; Carrega P; Cantoni C; Costa G; Accolla RS; Mingari MC; Ferrini S; Moretta L; Ferlazzo G
    Int Immunol; 2009 May; 21(5):599-606. PubMed ID: 19325034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The implications of IL-15 trans-presentation on the immune response.
    Waldmann TA; Waldmann R; Lin JX; Leonard WJ
    Adv Immunol; 2022; 156():103-132. PubMed ID: 36410873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-15 in autoimmunity.
    Allard-Chamard H; Mishra HK; Nandi M; Mayhue M; Menendez A; Ilangumaran S; Ramanathan S
    Cytokine; 2020 Dec; 136():155258. PubMed ID: 32919253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases.
    Waldmann TA
    Arthritis Res Ther; 2004; 6(4):174-7. PubMed ID: 15225362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.
    Waldmann TA; Conlon KC; Stewart DM; Worthy TA; Janik JE; Fleisher TA; Albert PS; Figg WD; Spencer SD; Raffeld M; Decker JR; Goldman CK; Bryant BR; Petrus MN; Creekmore SP; Morris JC
    Blood; 2013 Jan; 121(3):476-84. PubMed ID: 23212516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-15Rα membrane anchorage in either
    Quéméner A; Morisseau S; Sousa RP; Trillet K; Maillasson M; Leray I; Jacques Y; Dion J; Barbieux I; Frutoso M; Laurent AD; Le Questel JY; Mortier E
    J Cell Sci; 2019 Dec; 133(5):. PubMed ID: 31653781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patients.
    Carayol G; Giron-Michel J; Azzarone B; Castagna L; Cambier N; Mishal Z; Bourhis JH; Chouaib S; Caignard A
    Oncogene; 2000 May; 19(23):2758-66. PubMed ID: 10851076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
    Coskun M; Salem M; Pedersen J; Nielsen OH
    Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
    Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
    J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of IL-17A blockade with secukinumab in autoimmune diseases.
    Patel DD; Lee DM; Kolbinger F; Antoni C
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii116-23. PubMed ID: 23253932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation.
    Van den Bergh JM; Lion E; Van Tendeloo VF; Smits EL
    Pharmacol Ther; 2017 Feb; 170():73-79. PubMed ID: 27777088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of interleukin-21, interleukin-21 receptor alpha and related type I cytokines by intravascular graft leukocytes during acute renal allograft rejection.
    Hecker A; Kaufmann A; Hecker M; Padberg W; Grau V
    Immunobiology; 2009; 214(1):41-9. PubMed ID: 19159826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of a functional hybrid receptor gammac/GM-CSFRbeta in human hematopoietic CD34+ cells.
    Giron-Michel J; Fogli M; Gaggero A; Ferrini S; Caignard A; Brouty-Boye D; Baouz S; Le Bousse-Kerdiles MC; Peault B; van Dijk M; Bulfone-Paus S; Durali D; Chouaib S; Azzarone B
    J Exp Med; 2003 Mar; 197(6):763-75. PubMed ID: 12642604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-15 and IL-15Ralpha in CD4+T cell immunity.
    Van Belle T; Grooten J
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):115-26. PubMed ID: 15928580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tofacitinib and other kinase inhibitors in the treatment of psoriasis.
    Ortiz-Ibáñez K; Alsina MM; Muñoz-Santos C
    Actas Dermosifiliogr; 2013 May; 104(4):304-10. PubMed ID: 23583515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases.
    Clark JD; Flanagan ME; Telliez JB
    J Med Chem; 2014 Jun; 57(12):5023-38. PubMed ID: 24417533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-6: designing specific therapeutics for a complex cytokine.
    Garbers C; Heink S; Korn T; Rose-John S
    Nat Rev Drug Discov; 2018 Jun; 17(6):395-412. PubMed ID: 29725131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.